Judgment often impossible without randomized trials. Commentary on N. Patel: use of milrinone to treat cardiac dysfunction in infants with pulmonary hypertension secondary to congenital diaphragmatic hernia: a review of six patients (Neonatology 2012;102:130-136).
Division of Neonatology, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Annie
A
Giaccone
Haresh
H
Kirpalani
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D065627:Familial Primary Pulmonary Hypertension; D005260:Female; D006548:Hernia, Diaphragmatic / Q000150:complications; D065630:Hernias, Diaphragmatic, Congenital; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D008297:Male; D020105:Milrinone / Q000627:therapeutic use*; D058987:Phosphodiesterase 3 Inhibitors / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*; D018497:Ventricular Dysfunction, Right / Q000188:drug therapy*
D000959:Antihypertensive Agents; D002316:Cardiotonic Agents; D058987:Phosphodiesterase 3 Inhibitors; D014665:Vasodilator Agents; D020105:Milrinone